Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized withdrawal study of vixotrigine in trigeminal neuralgia
2016-001449-16Phase 3Active
- Sponsor
- Biogen
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in trigeminal neuralgia (TN) comparing Vixotrigine arm with Placebo arm (2 arms). Primary endpoint: Responder rate at Week 12. Started Dec 2016; status: active.
02
Drugs
vixotrigine
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on 2016-001449-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001449-16.